Free Newsletter
U.K. approves 'cybrids' for stem cell research
In the interest of making more and better human stem cells for research, U.K. regulators have approved the creation of short-lived human/animal hybrid embryos. Only tiny fragments of animal DNA will be used, they say, and no freaks of nature will be unleashed. These will be the first human/animal embryos allowed for research. The first cytoplasmic hybrid embryos--dubbed cybrids--should be created by the end of the year. There's still a chance that opponents could block the move in court.
Several research teams have been seeking permission to create cybrids for work on Alzheimer's and Parkinson's. Another team focused on motor neuron disease is also expected to file for approval as well.
- read the statement on the decision
- see the Times report
Related Article:
Human/animal chimeras get a reprieve in the U.K. Report
More stories about DNA Stem Cells Alzheimer's Parkinson Disease Regulators Cybrids Animal Hybrids Hybrid embryos
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: